Panel Discussion: Defining Quality in Oncology: Is There a Common Ground?

%jwplayer%

Although there have been some accusations of “cookbook medicine” with regards to measurement guidelines, panelists Dennis Scanlon, PhD, Jess DeMartino, PhD, Phyllis Torda, and Laura Long, MD, do see progress to remedy the situation and make guidelines more effective.

Part of the problem is in the measurement itself, according to Dr Scanlon, who recommends going back to the reason why the industry measures in the first place, such as for accountability, quality improvement, surveillance and payment purposes.

Dr Long added that guidelines should not just be for evidence-based care or efficacy but what is important to patients. The National Comprehensive Cancer Network, where Dr DeMartino works, aims to educate patients with their own set of guidelines that include glossary terms to explain concepts like deductibles and co-pays.

Ms Torda added that active promotion of patient involvement is becoming more common and patients are being engaged in 3 ways: directly in the delivery of their care; through advisory boards within practices; and with advocacy on the policy level.